Exact Mass: 273.1033
Exact Mass Matches: 273.1033
Found 128 metabolites which its exact mass value is equals to given mass value 273.1033,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
1,6-Dihydro-1-(3-methoxyphenethyl)-6-oxonicotinic acid
L-Thyronine
Thyronine (T0) is a de-iodinated form of thyroxine. Thyronine are a group of metabolites derived from thyroxine and triiodothyronine via the peripheral enzymatic removal of iodines from the thyroxine nucleus. Thyronine is the thyroxine nucleus devoid of its four iodine atoms. Thyronine (T0) has been identified in human urine. In 22 normal individuals urinary thyronine concentrations were found to range between 8-25 nmol‚ÅÑ24h (PMID: 479355). Thyronine is thought to be a byproduct of thyroxine metabolism and arises through the action of thyroxine deiodinases. Iodide is actively absorbed from the bloodstream and concentrated in the thyroid follicles. (If there is a deficiency of dietary iodine, the thyroid enlarges in an attempt to trap more iodine, resulting in goitre.) Via a reaction with the enzyme thyroperoxidase, iodine is covalently bound to tyrosine residues in the thyroglobulin molecules, forming monoiodotyrosine (MIT) and diiodotyrosine (DIT). Linking two moieties of DIT produces thyroxine. Combining one particle of MIT and one particle of DIT produces triiodothyronine. D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
Benzoic acid, 4-[[(2,5-dihydroxyphenyl)methyl]amino]-, methyl ester
N-Ethyl-N-(2-hydroxy-3-sulfopropyl)-3-toluidine
metazachlor OXA
A monocarboxylic acid that is oxoacetic acid substituted by a (2,6-dimethylphenyl)(1H-pyrazol-1-ylmethyl)amino group at position 2. It is metabolite of the herbicide metazachlor. CONFIDENCE standard compound; EAWAG_UCHEM_ID 706 CONFIDENCE standard compound; INTERNAL_ID 2062
3-(1-hydroxyethyl)-6-(indol-3-ylmethyl)-2,5-diketopiperazine|cyclo(L-Trp-L-Ser-)|cyclo(L-tryptophanyl-L-seryl)|cyclo-L-Trp-L-Ser
5-Hydroxymethylcytidine
5-(Hydroxymethyl)cytidine is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].
4-[3-(1,3-BENZODIOXOL-5-YL)-1,2,4-OXADIAZOL-5-YL]PIPERIDINE
methyl 5,5,5-trifluoro-4-(4-methylphenyl)iminopentanoate
methyl 5,5,5-trifluoro-4-(2-methylphenyl)iminopentanoate
methyl 5,5,5-trifluoro-4-(3-methylphenyl)iminopentanoate
7-Chloro-2-[[[(1S)-2,2-dimethylcyclopropyl]carbonyl]amino]-2-heptenoic acid
(1S)-1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethanamine
(Meso-1R,5S,6R)-Ethyl 3-Benzyl-2,4-Dioxo-3-Azabicyclo[3.1.0]Hexane-6-Carboxylate
(S)-MORPHOLINE-3,4-DICARBOXYLICACID4-TERT-BUTYLESTER
1-Benzyl-3-trifluoromethyl-pyrrolidine-3-carboxylic acid
6-(ALLYLOXY)-1-ETHYL-4-OXO-1,4-DIHYDROQUINOLINE-2-CARBOXYLIC ACID
2-CYCLOHEXYL-1,3-DIOXO-2,3-DIHYDRO-1 H-ISOINDOLE-5-CARBOXYLIC ACID
Naphazoline nitrate
C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist D019141 - Respiratory System Agents > D014663 - Nasal Decongestants D002317 - Cardiovascular Agents > D014662 - Vasoconstrictor Agents Naphazoline (Naphthazoline) nitrate is an α-adrenergic receptor agonist. Naphazoline nitrate reduces vascular hyperpermeability and promotes vasoconstriction. Naphazoline nitrate reduces the levels of inflammatory factors (TNF-α, IL-1β and IL-6), cytokines (IFN-γ and IL-4), IgE, GMCSF, and NGF。Naphazoline nitrate can be used for non-bacterial conjunctivitis research[1][2].
2-(2-PYRIDIN-2-YL-1H-INDOL-3-YL)ETHANAMINE MONOHYDROCHLORIDE
2-(2-PYRIDIN-3-YL-1H-INDOL-3-YL)ETHANAMINE MONOHYDROCHLORIDE
2-(2-PYRIDIN-4-YL-1H-INDOL-3-YL)ETHANAMINE MONOHYDROCHLORIDE
2-(tert-Butyl)-3-hydroxy-4-(trifluoromethyl)isoindolin-1-one
2-(tert-Butyl)-3-hydroxy-5-(trifluoromethyl)isoindolin-1-one
ETHYL 2-ISOPROPOXY-4-METHOXYBENZIMIDATE HYDROCHLORIDE
1-Methyl-1-propylpyrrolidinium hexafluorophosphate
1-tert-butoxycarbonylisoquinoline-3-carboxylic acid
1-(3-Ethoxy-4-methoxyphenyl)-2-(methylsulfonyl) ethanamine
1-(4-Trifluoromethylphenyl)piperidine-4-carboxylic acid
2-(tert-Butyl)-3-hydroxy-6-(trifluoromethyl)isoindolin-1-one
(R)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethanamine
3-Amino-6-(4-methylphenyl)pyrazinecarboxylicacidethylester-4-oxide
1-Benzyl-4-trifluoromethyl-pyrrolidine-3-carboxylic acid
Pyrrole-2,4-dicarboxylic acid, 3,5-dimethyl-, 4-benzyl ester (7CI)
(R)-(+)-alpha-[(3-Methoxy-1-methyl-3-oxo-1-propenyl)amino]-1,4-cyclohexadiene-1-acetic acid sodium salt
1,6-Dihydro-4-hydroxy-2-methyl-6-oxo-1-phenyl-3-pyridinecarboxylic acid ethyl ester
2-propenoic acid, 3-[2-[(3,5-dimethyl-4-isoxazolyl)methoxy
Viloxazine hydrochloride
D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors > D018759 - Adrenergic Uptake Inhibitors C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C185721 - Norepinephrine Reuptake Inhibitor D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents D049990 - Membrane Transport Modulators
3-(1,2,3,4-TETRAHYDROQUINOLIN-2-YL)-2-(TRIFLUOROMETHYL) PROPIONIC ACID
4-[2-(Methyl-2-pyridinyl)amino]ethoxyl nitrobenzene
Benzoic acid, 4-[[(2,5-dihydroxyphenyl)methyl]amino]-, methyl ester
D000970 - Antineoplastic Agents > D020032 - Tyrphostins
4-(5-Methoxy-1,2-dimethyl-1h-indol-3-yl)thiazol-2-ylamine
BENZOIC ACID, p-((2,4,6-TRIAMINO-5-PYRIMIDINYL)AZO)-
N-[4-(2-pyridinyl)-2-thiazolyl]cyclopentanecarboxamide
1-[2-(3-Methoxyphenyl)ethyl]-6-oxo-1,6-dihydropyridine-3-carboxylic acid
2-[4-(aminomethyl)phenyl]-3,5,7,8-tetrahydro-4H-thiino[4,3-d]pyrimidin-4-one
(2S)-2-azaniumyl-3-[4-(4-hydroxyphenoxy)phenyl]propanoate
2-[[1-(4-Ethoxyphenyl)-2,5-dioxo-3-pyrrolidinyl]amino]acetonitrile
1-(4-Methoxyphenyl)-3-(6-methyl-2-pyridinyl)thiourea
N-(2,3-dihydro-1,4-benzodioxin-6-yl)-1,5-dimethyl-4-pyrazolecarboxamide
N-(2,3-dihydro-1,4-benzodioxin-6-yl)-2,5-dimethyl-3-furamide
4-[[2-Furanyl(oxo)methyl]amino]benzoic acid propan-2-yl ester
3-[1-(Carboxymethyl)-5-phenyl-2-pyrrolyl]propanoic acid
4-(2,4-dimethoxyphenyl)-3-methyl-4,5-dihydro-2H-pyrrolo[3,4-c]pyrazol-6-one
methyl (4Z)-4-(furan-2-ylmethylidene)-2-methyl-5-oxo-1-prop-2-enylpyrrole-3-carboxylate
(E)-3-(Ethoxycarbonylmethylene)-1-para-tolyl-2,5-pyrrolidinedione
SIB-1553A
SIB-1553A is an orally bioavailable nicotinic acetylcholine receptors (nAChRs) agonist, with selectivity for β4 subunit-containing nAChRs. SIB-1553A is also a selective neuronal nAChR ligand. SIB-1553A is a cognitive enhancer, and has therapeutic potential for the symptomatic treatment of Alzheimer’s disease and other cognitive disorders[1][2].
